Clinical Study
Acute Experimental Hyperthyroidism Does Not Affect Basal and Volume-Induced Atrial Natriuretic Peptide Secretion in Healthy Subjects
Table 1
Clinical and laboratory characteristics of the study population before and after T3 administration.
| Parameter | Before T3 | After T3 | P value |
| Heart rate, beats/min | | | .061 | Mean blood pressure, mmHg | | | .966 | T3, nmol/L | | | .001 | T4, nmol/L | | | .018 | TSH, μU/mL | | | .001 | ANP, pmol/L | | | .256 | PRA, nmol/L/h | | | .099 | ALDO, pmol/L | | | .836 |
|
|
ALDO: plasma aldosterone; ANP: plasma atrial natriuretic peptide; PRA, plasma renin activity.
|